Hepatitis B information for healthcare and public health professionals

This clinical advisory addresses increased hepatitis B transmission associated with injection drug use in Southeastern Massachusetts related to the ongoing epidemic of substance use.

This report presents data through 2023 for hepatitis A, B, and C reported to Massachusetts Department of Public Health by health care providers and laboratories consistent with regulation (105 CMR 300.000). The report contains detailed tables and figures describing viral hepatitis infections in Massachusetts.

This report presents data on the diseases reported to the Bureau of Infectious Disease and Laboratory Sciences by healthcare providers and laboratories per regulation (105 CMR 300.000). This report focuses on a subset of these diseases and includes: chlamydia, gonorrhea, hepatitis B, hepatitis C, HIV/AIDS, and syphilis

This report examines HIV and viral hepatitis co-infection in Massachusetts.

Information regarding case reporting and hepatitis B (HBV) case report forms

Information on vaccination rates and when and why hepatitis B vaccine is recommended

Hepatitis B virus (HBV) infection in a pregnant woman poses a serious risk to her infant at birth. Providers involved with the care of pregnant women and their infants should follow certain guidelines discussed on the Perinatal HBV page.

The CDC provides resources for health care providers and public health professionals on a variety of topics, including general information regarding transmission and prevention, statistics about HBV, diagnosis and management of HBV infection, and other resources for health care professionals.

Find information about using mobile messaging services to offer clients a new way to notify partners and to help partners to schedule appointments for testing and treatment.